StocksAscendis PharmaASND

ASND

Ascendis Pharma

116.16 2.58 (2.27%)
Försenade priser från NASDAQ, i USD Marknaden stängd
Handla
S
115.93
K
116.70
Topp
DeepNews
$ASND (Ascendis Pharma) Ascendis' (ASND) TransCon hGH Gets EU Nod for Pediatric GHD Ascendis Pharma A/S ASND announced that the European Commission has granted marketing authorization to TransCon hGH (Lonapegsomatropin Ascendis Pharma) for the treatment of growth hormone deficiency (“GHD”) in... Visa mer Översätt
DeepNews
$ASND (Ascendis Pharma) Ascendis Pharma's Growth Hormone Deficiency Med Scores European Approval The European Commission (EC) has granted marketing authorization to Ascendis Pharma A/S's (NASDAQ: ASND) Lonapegsomatropin (developed under the name TransCon hGH). The approval for TransCon covers... Visa mer Översätt
DeepNews
$ASND (Ascendis Pharma) Ascendis Pharma A/S Provides Update on Vision 3x3 Strategic Roadmap at 40th Annual J.P. Morgan Healthcare Conference A/S (Nasdaq: ASND) today announced that the Company will today provide an update on its Vision 3x3 and planned 2022 key milestones at the 40th Annual J.P. Morgan... Visa mer Översätt
DeepNews
$ASND (Ascendis Pharma) Ascendis Pharma A/S to Participate in 40th Annual J.P. Morgan Healthcare Conference A/S (Nasdaq: ASND) today announced that the Company is scheduled to participate in the upcoming 40th Annual J.P. Morgan Healthcare Conference. Company executives will provide a business overview... Visa mer Översätt
VolatilityAlerts
$ASND (Ascendis Pharma) rises 6.0% - Will it keep climbing?Översätt
ASND
Ascendis Pharma
115.93
2.58 (2.27%)